Motala C, Hill I D, Mann M D, Bowie M D
Department of Paediatrics and Child Health, University of Cape Town, South Africa.
J Pediatr. 1990 Sep;117(3):467-71. doi: 10.1016/s0022-3476(05)81100-x.
This study was designed to assess the effect of loperamide, given to infants in higher than recommended doses, on the severity and duration of acute diarrhea. Thirty infants with acute diarrhea and dehydration were given loperamide (0.8 mg/kg/day), in addition to standard fluid therapy, for 48 hours after admission to the hospital. The stool output in grams per kilograms of body weight per day and the duration of diarrhea in these infants were compared with those in 30 matched control infants receiving only standard fluid therapy. Two infants given loperamide had to be withdrawn from the trial because ileus developed in one and the other had persistent severe vomiting. In four other infants receiving loperamide, drowsiness developed but resolved rapidly on discontinuation of the drug. Infants receiving loperamide had a shorter duration of diarrhea (median 2.5 vs 6.0 days) and lower daily stool output than the control subjects had. The study confirmed the efficacy of loperamide in reducing the duration and severity of diarrhea but raised doubts regarding its safety in the treatment of young infants.
本研究旨在评估给予婴儿高于推荐剂量的洛哌丁胺对急性腹泻严重程度和持续时间的影响。30名患有急性腹泻和脱水的婴儿在入院后除接受标准液体疗法外,还给予洛哌丁胺(0.8毫克/千克/天),持续48小时。将这些婴儿每天每千克体重的粪便排出量和腹泻持续时间与30名仅接受标准液体疗法的匹配对照婴儿进行比较。两名接受洛哌丁胺治疗的婴儿不得不退出试验,因为其中一名出现肠梗阻,另一名持续严重呕吐。在其他四名接受洛哌丁胺治疗的婴儿中,出现了嗜睡,但停药后很快缓解。接受洛哌丁胺治疗的婴儿腹泻持续时间较短(中位数为2.5天对6.0天),且每日粪便排出量低于对照组。该研究证实了洛哌丁胺在缩短腹泻持续时间和减轻腹泻严重程度方面的疗效,但对其在治疗幼儿时的安全性提出了质疑。